van der Voort A, Louis FM, van Ramshorst MS, Kessels R, et al. MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study. Lancet Oncol 2024 Apr 5:S1470-2045(24)00104.
PMID: 38588682